Literature DB >> 20096126

Impaired plasma lipid profiles in acute hepatitis.

Libo Luo1, Xiangke Pu, Yongzhong Wang, Ning Xu.   

Abstract

The present study examined plasma lipid profiles in thirty patients suffered from acute viral hepatitis. Patients' blood samples were collected at both the debut and recovery of diseases. Thirty sex and age matched normal subjects were included as controls. Plasma total triglycerides (TG), total cholesterol, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein AI (ApoAI), apolipoprotein B (ApoB), lipoprotein (a) (Lp(a)), blood coagulation status including prothrombin complex activity and activated partial tromboplastin time (APTT), and hepatic functions were determined by the automatic biochemical analytical instrument. It demonstrated that plasma levels of total cholesterol, HDL-C and apoAI were significantly lower in the patients at the acute phase of hepatitis than those in normal subjects, whereas plasma levels of TG and LDL-C were obviously higher in the patients than in normal subjects (P < 0.05). Moreover, we demonstrated that patients' plasma levels of total cholesterol, LDL-C, HDL-C and apoAI were lower at the active phase of the diseases than at the recovering phase, which indicating that acute liver damage could significant influence lipid metabolism in vivo. No pathological changes of blood coagulation status occurred in these patients during the study as all selected patients had moderate hepatitis. It may conclude that examinations of plasma lipid profile could be considered as a clinical index to reflect liver damage in the active phase of hepatitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096126      PMCID: PMC2824760          DOI: 10.1186/1476-511X-9-5

Source DB:  PubMed          Journal:  Lipids Health Dis        ISSN: 1476-511X            Impact factor:   3.876


  20 in total

1.  Lack of effect of acute alcohol ingestion on plasma lipids.

Authors:  S Booth; P M Clifton; P J Nestel
Journal:  Clin Chem       Date:  1991-09       Impact factor: 8.327

Review 2.  Lipid metabolism in liver and selected tissues and in the whole body of ruminant animals.

Authors:  A W Bell
Journal:  Prog Lipid Res       Date:  1979       Impact factor: 16.195

3.  Receptor-mediated catabolism of homologous low density lipoproteins in cultured pig hepatocytes.

Authors:  S H Pangburn; R S Newton; C M Chang; D B Weinstein; D Steinberg
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

Review 4.  Dyslipoproteinaemia of liver disease.

Authors:  J P Miller
Journal:  Baillieres Clin Endocrinol Metab       Date:  1990-12

5.  Low plasma apolipoprotein A-I level: new prognostic criterion in childhood cirrhosis?

Authors:  M A Selimoğlu; S Aydoğdu; R V Yağci
Journal:  Turk J Pediatr       Date:  2001 Oct-Dec       Impact factor: 0.552

6.  Apolipoproteins A-I, A-II and B in chronic active hepatitis and in liver cirrhotic patients.

Authors:  C Cordova; A Musca; F Violi; C Alessandri; L Iuliano
Journal:  Clin Chim Acta       Date:  1984-02-14       Impact factor: 3.786

7.  Serum total lipids, lipoprotein cholesterol, and apolipoprotein A in acute viral hepatitis and chronic liver disease.

Authors:  C Vergani; G Trovato; A Delù; M Pietrogrande; N Dioguardi
Journal:  J Clin Pathol       Date:  1978-08       Impact factor: 3.411

Review 8.  [Apolipoprotein A-I, E, C-III and LDL-receptor mRNA expression in liver diseases].

Authors:  N Fukushima; K Yamamoto; I Ozaki; T Sakai
Journal:  Nihon Rinsho       Date:  1993-02

9.  Naltrexone protects against lipopolysaccharide/D-galactosamine-induced hepatitis in mice.

Authors:  Chien-Chuan Wang; Pao-Yun Cheng; Yie-Jen Peng; Edwin Sc Wu; Hsiao-Ping Wei; Mao-Hsiung Yen
Journal:  J Pharmacol Sci       Date:  2008-11       Impact factor: 3.337

10.  [Importance of apolipoproteins A-1 and B in acute viral hepatitis and hepatic cirrhosis].

Authors:  A D Jorge; G Ponce; C Milutín; D Sánchez; M Díaz; R Pérez; C Esley
Journal:  Acta Gastroenterol Latinoam       Date:  1986
View more
  6 in total

Review 1.  Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Anton Stalenhoef
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-10-17       Impact factor: 4.690

2.  Serum sphingosine-1 phosphate level is increased in patients with hepatitis B and displays a positive association with liver fibrosis.

Authors:  Mei Sun; Ling Zeng; Min Hu
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

Review 3.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef
Journal:  J Clin Endocrinol Metab       Date:  2012-09       Impact factor: 5.958

4.  Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B.

Authors:  Ting Shen; Wei Min Wu; Wen Han Du; Lin Wang; La Gu He; Li Tan; ZeYou Wang; Ruohong Chen; Min Hu; Ya Ping Ren
Journal:  Lipids Health Dis       Date:  2016-12-07       Impact factor: 3.876

5.  Hepatitis B virus inhibits apolipoprotein A5 expression through its core gene.

Authors:  Chengliang Zhu; Guosheng Gao; Hui Song; Fengxia Xu; Kailang Wu; Xinghui Liu
Journal:  Lipids Health Dis       Date:  2016-10-10       Impact factor: 3.876

Review 6.  Advances in Hepatitis E Virus Biology and Pathogenesis.

Authors:  Shaoli Lin; Yan-Jin Zhang
Journal:  Viruses       Date:  2021-02-09       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.